(8β)-8-[[[(1,1-Dimethylethyl)dimethylsilyl]oxy]methyl]ergoline
| Product Name |
(8β)-8-[[[(1,1-Dimethylethyl)dimethylsilyl]oxy]methyl]ergoline
|
| Product Code |
DA-C003-06
|
| Chemical name |
(8β)-8-[[[(1,1-Dimethylethyl)dimethylsilyl]oxy]methyl]ergoline
|
| Synonyms |
(6aR,9R,10aR)-9-(((Tert-butyldimethylsilyl)oxy)methyl)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline;
|
| Impurity |
NA
|
| CAS Number |
1075250-74-6
|
| Alternate CAS # |
NA
|
| Molecular form |
C21H32N2OSi
|
| Appearance |
Off-White Solid
|
| Melting Point |
NA
|
| Mol. Weight |
356.59
|
| Storage |
2-8°C Refrigerator
|
| Solubility |
NA
|
| Stability |
NA
|
| Category |
neurochemicals,pharmaceutical standards,impurities,metabolites,fine chemicals
|
| Boiling Point |
NA
|
| Applications |
(8β)-8-[[[(1,1-Dimethylethyl)dimethylsilyl]oxy]methyl]ergoline is an protected intermediate in the synthesis of cabergoline which is a dopamine D2-receptor agonist
|
| Dangerous Goods Info |
NA
|
| References |
NA
|
| Extra Notes |
NA
|
| Documents (MSDS) |
No Data Available
|
| Keywords |
NA |
